Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04096417
Title Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
Aurora Cancer Care-Milwaukee West Wauwatosa Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field